February 09 – BELNUC General Assembly & Nuclear Medicine in Neurology

Dear members,

we are glad to announce the final program of the BELNUC seminar dedicated to neurology that will take place after the BELNUC 2019 general assembly on the 9th of February 2019.

Please note that the venue is different from previous seminars!

Venue: Maria-Theresia College, Sint-Michielsstraat 6, 3000 Leuven.  Auditorium MTC3 00.15
Parking Herman Servotte (no code needed): Parkstraat 39 : -1 (91); -2 (92) and -3 (93)

Accreditation:

FANC/AFCN: 2h granted for physicians and qualified persons in NM;

RIZIV/INAMI activity number 18018594: 2h/2CP (category: general)

8:30 Coffee & croissants

9:00-9:45: BELNUC 2019 General Assembly

Agenda

2018 Accounts

2018 Membership

2019 Budget

BELNUC Bank Accounts

BELNUC Administrative office

BELNUC Activities

BELNUC Workgroups achievement

2019 Membership fees

Discharge of the leaving Board Members:

I. Goethals, Y. D´Asseler, Z. Wimana and G. Namur

Presentation of board candidates:

General secretary candidate (1 position):

Dr Prof Tim Van den Wyngaert (University of Antwerp, Antwerp University Hospital)

Board members candidates (3 positions):

Dr Prof Patrick Flamen (Jules Bordet Institute), Dr Félicie Sherer (Centre hospitalier Epicura), Filip De Vos (radiopharmacist, UGent) and Gwennaëlle Marin (Jules Bordet Institute)

Election

Note that, according to BELNUC statutes, only 2018 BELNUC members (cotisation paid by December 31, 2018) are allowed to vote

9:45-10:00 Coffee break (short)

10:00-12:30 BELNUC SEMINAR: Nuclear medicine in Neurology

10:00-10:30:  Brain MR imaging: A focus on new MRI-techniques

Prof Dr Marion Smits (Erasmus MC-University Medical Centre Rotterdam, Netherlands)

10:30-11:00: Amino acid PET Imaging

Prof Dr Karolien Goffin (UZ Leuven)

11:00-11:30: Coffee break

11:30-12:00: Molecular imaging of movement disorders

Prof Dr Koen Van Laere (UZ Leuven)

12:00-12:30: PET in Dementia: an update

Prof. Dr John O’Brien (University of Cambridge School of Clinical Medicine, Cambridge, UK)

Sincerely,

the BELNUC board